Funding tracker

Boltz raised $110M

$110MRaised
Series AStage
18 Nov 2026Date
61.1KViews on the announcement

The round

Amount$110M
StageSeries A
InvestorsBessemer (lead)
What they doAI drug design software
VerticalHealth and bio
First reportedWednesday, 18 November 2026

The announcement on X

The median tracked announcement from accounts with 10K to 100K followers reached 61.1K views (47 posts). This one did 1x that.

We’ve raised $110M to bring AI-powered biomolecular design to every scientist! Boltz’s Series A is led by @BessemerVP, following 50-fold growth in molecular token usage from our users since June and partnerships with 6 of the world’s 20 largest pharma companies. https://t.co/3rBJvf055v
Posted by@GabriCorso (Gabriele Corso)
Followers11,204
Views61,109
Views per follower5.5x
Likes616
Reposts68
Bookmarks149

Similar rounds

CompanyStageAmountLeadOn XDate
IsomorphicAI drug discoverySeries C$5B--18 Nov 2026
Ansa BiotechnologiesEnzymatic DNA synthesisSeries C$71.5M-12718 Nov 2026
Humyn LabsPhysical AISeries A$47MAccel109.9K18 Nov 2026
DcubedSpace deployment and power systemsSeries A€27.2MWarsaw Equity Group-18 Nov 2026
AveniaBrazilian stablecoin infrastructureSeries A$25M-57218 Nov 2026
SirenOptReal-time materials characterization for manufacturingSeries A$25M-34618 Nov 2026

Next launch

Planning a launch?

Tell us what is launching and when. Thirty minutes is usually enough to know whether we are the right team for it.